MHC-1B carried exosomes derived from tubular epithelial cell induced by the EGFR mimotope inhibit macrophage activation in renal fibrosis
The high prevalence of chronic kidney disease (CKD) is a significant public health burden worldwide. Renal fibrosis is an inevitable pathological process in almost all CKD cases. To date, the available treatments to prevent or delay renal fibrosis progression are limited. Epidermal growth factor rec...
Saved in:
Published in | Extracellular Vesicle (Online) Vol. 2; p. 100024 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier
01.12.2023
|
Subjects | |
Online Access | Get full text |
ISSN | 2773-0417 2773-0417 |
DOI | 10.1016/j.vesic.2023.100024 |
Cover
Loading…
Abstract | The high prevalence of chronic kidney disease (CKD) is a significant public health burden worldwide. Renal fibrosis is an inevitable pathological process in almost all CKD cases. To date, the available treatments to prevent or delay renal fibrosis progression are limited. Epidermal growth factor receptor (EGFR) mimotope has been demonstrated to alleviate renal fibrosis in the unilateral ureteric obstruction (UUO) model as a type of vaccine. Further observations suggested that the EGFR mimotope can inhibit the activation of macrophages, which play a vital role in renal fibrosis. In the current study, we explored the link triggered by the EGFR mimotopes between tubular epithelial cells (TECs) and macrophages. A series of experiments indicated that EGFR mimotope immunization can inhibit the activation of THP-1 macrophages by TEC-derived exosomes. Injection of these exosomes ameliorated renal fibrosis in the UUO model. Mechanism analysis suggested that the major histocompatibility complex-1B (MHC-1B) was the key molecule in the TECs exosomes induced by EGFR mimotope immunization and is regulated by ribosomal protein L6 (RPL-6). This study revealed a new specific working path of the EGFR mimotope and suggests that the application of the EGFR mimotope can be extended to other immune-related disorders. |
---|---|
AbstractList | The high prevalence of chronic kidney disease (CKD) is a significant public health burden worldwide. Renal fibrosis is an inevitable pathological process in almost all CKD cases. To date, the available treatments to prevent or delay renal fibrosis progression are limited. Epidermal growth factor receptor (EGFR) mimotope has been demonstrated to alleviate renal fibrosis in the unilateral ureteric obstruction (UUO) model as a type of vaccine. Further observations suggested that the EGFR mimotope can inhibit the activation of macrophages, which play a vital role in renal fibrosis. In the current study, we explored the link triggered by the EGFR mimotopes between tubular epithelial cells (TECs) and macrophages. A series of experiments indicated that EGFR mimotope immunization can inhibit the activation of THP-1 macrophages by TEC-derived exosomes. Injection of these exosomes ameliorated renal fibrosis in the UUO model. Mechanism analysis suggested that the major histocompatibility complex-1B (MHC-1B) was the key molecule in the TECs exosomes induced by EGFR mimotope immunization and is regulated by ribosomal protein L6 (RPL-6). This study revealed a new specific working path of the EGFR mimotope and suggests that the application of the EGFR mimotope can be extended to other immune-related disorders. |
ArticleNumber | 100024 |
Author | Guo, Jin Liu, Xuanqi Song, Haoming Yang, Lin Niu, Jianying Gu, Yong |
Author_xml | – sequence: 1 givenname: Jin surname: Guo fullname: Guo, Jin – sequence: 2 givenname: Xuanqi surname: Liu fullname: Liu, Xuanqi – sequence: 3 givenname: Haoming surname: Song fullname: Song, Haoming – sequence: 4 givenname: Yong surname: Gu fullname: Gu, Yong – sequence: 5 givenname: Jianying surname: Niu fullname: Niu, Jianying – sequence: 6 givenname: Lin orcidid: 0000-0002-9206-791X surname: Yang fullname: Yang, Lin |
BookMark | eNp9kcuKFDEUhoOM4DjOE7jJC1SbW1U6S23mBiOC6DqcJKem01RVmiTdOI_gW5vpFhEXrhK-c_4Pkv8tuVjSgoS852zFGR8-7FZHLNGvBBOyEcaEekUuhdayY4rri7_ub8h1Kbu2IoXSPReX5Ofn-03HP1EPOUcMFH-kkmYsNGCOxwbGnGZaD-4wQaa4j3WLU4SJepwmGpdw8G3JPdPG6c3d7Vc6xznVtMc23EYXK53B57TfwhNS8DUeoca0tCnNuDTRGF1OJZZ35PUIU8Hr3-cV-X57821z3z1-uXvYfHzsvOiN6rT3vQtKDFIMa-7QKL7m0Et06HqnnQAzIpgAHtlg1v2o-uBCGIQKhmsl5BV5OHtDgp3d5zhDfrYJoj2BlJ8s5Br9hDYI40GOegjeKK9wrZAHLYE5jY2x5pJnV3thKRnHPz7O7Es5dmdP5diXcuy5nJYy_6R8rKdfqRni9N_sL2Slm3o |
CitedBy_id | crossref_primary_10_1016_j_toxrep_2024_05_001 crossref_primary_10_2147_IJN_S452393 |
Cites_doi | 10.1016/j.matbio.2018.02.006 10.1016/S0140-6736(16)32064-5 10.1016/j.chom.2020.04.010 10.1517/14712590902870386 10.1038/s41419-018-1157-x 10.1016/j.gpb.2015.02.001 10.1038/nrneph.2016.91 10.1016/j.kint.2017.02.006 10.5483/BMBRep.2019.52.9.193 10.1016/j.phymed.2022.154206 10.2217/imt-2018-0213 10.1016/0378-1119(93)90152-S 10.1016/0378-1119(93)90148-V 10.7150/ijbs.62478 10.1016/j.imlet.2007.07.008 10.1038/s41419-021-03460-x 10.1016/j.kint.2019.11.026 10.1002/1521-4141(200212)32:12<3425::AID-IMMU3425>3.0.CO;2-7 10.1073/pnas.87.6.2137 10.1186/s12943-020-01238-x 10.3390/cancers12061553 10.1016/j.smim.2020.101395 10.1007/s00262-010-0872-7 10.1016/j.molcel.2018.12.020 10.1615/CritRevImmunol.v17.i3-4.20 10.1016/j.clim.2019.05.014 10.1016/j.clim.2016.01.006 10.1146/annurev-biochem-013118-111902 10.7150/thno.62820 10.1681/ASN.2012101031 10.1016/j.kint.2017.09.033 10.3389/fimmu.2018.01869 |
ContentType | Journal Article |
DBID | AAYXX CITATION DOA |
DOI | 10.1016/j.vesic.2023.100024 |
DatabaseName | CrossRef DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2773-0417 |
ExternalDocumentID | oai_doaj_org_article_d29ca3f76dc94c4e84e1d73a0b7e6dc0 10_1016_j_vesic_2023_100024 |
GroupedDBID | 0R~ AALRI AAXUO AAYWO AAYXX ACVFH ADCNI ADVLN AEUPX AEXQZ AFJKZ AFPUW AIGII AITUG AKBMS AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP CITATION EBS FDB GROUPED_DOAJ M~E ROL |
ID | FETCH-LOGICAL-c2594-7cc5bd42632681be94181a53ebeb5b7b2a9fea9dace06985f45dbdd624d917423 |
IEDL.DBID | DOA |
ISSN | 2773-0417 |
IngestDate | Wed Aug 27 01:29:39 EDT 2025 Tue Jul 01 02:29:08 EDT 2025 Thu Apr 24 23:06:52 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c2594-7cc5bd42632681be94181a53ebeb5b7b2a9fea9dace06985f45dbdd624d917423 |
ORCID | 0000-0002-9206-791X |
OpenAccessLink | https://doaj.org/article/d29ca3f76dc94c4e84e1d73a0b7e6dc0 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_d29ca3f76dc94c4e84e1d73a0b7e6dc0 crossref_primary_10_1016_j_vesic_2023_100024 crossref_citationtrail_10_1016_j_vesic_2023_100024 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-12-00 2023-12-01 |
PublicationDateYYYYMMDD | 2023-12-01 |
PublicationDate_xml | – month: 12 year: 2023 text: 2023-12-00 |
PublicationDecade | 2020 |
PublicationTitle | Extracellular Vesicle (Online) |
PublicationYear | 2023 |
Publisher | Elsevier |
Publisher_xml | – name: Elsevier |
References | Hashemi (10.1016/j.vesic.2023.100024_b37) 2020; 12 Zhao (10.1016/j.vesic.2023.100024_b21) 2021; 18 Zhou (10.1016/j.vesic.2023.100024_b24) 2021; 14 Yang (10.1016/j.vesic.2023.100024_b10) 2016; 163 Liu (10.1016/j.vesic.2023.100024_b23) 2021; 3 Law (10.1016/j.vesic.2023.100024_b32) 2017; 1 Zhang (10.1016/j.vesic.2023.100024_b19) 2015; 1 Pourjafar (10.1016/j.vesic.2023.100024_b4) 2019; 9 Abel (10.1016/j.vesic.2023.100024_b35) 2018; 9 Felici (10.1016/j.vesic.2023.100024_b5) 1993; 128 Yang (10.1016/j.vesic.2023.100024_b12) 2010; 59 Riemer (10.1016/j.vesic.2023.100024_b7) 2007; 113 Slansky (10.1016/j.vesic.2023.100024_b9) 2020; 47 Schott (10.1016/j.vesic.2023.100024_b30) 2002; 12 Tobias (10.1016/j.vesic.2023.100024_b3) 2022; 1 Knittelfelder (10.1016/j.vesic.2023.100024_b8) 2009; 4 Hughes (10.1016/j.vesic.2023.100024_b13) 1999; 277 Borges (10.1016/j.vesic.2023.100024_b20) 2013; 3 Wee (10.1016/j.vesic.2023.100024_b33) 2019; 9 Harskamp (10.1016/j.vesic.2023.100024_b2) 2016; 8 Jablonski (10.1016/j.vesic.2023.100024_b14) 2015; 12 Guan (10.1016/j.vesic.2023.100024_b22) 2020; 2 Gewin (10.1016/j.vesic.2023.100024_b16) 2018; 68–69 Pegtel (10.1016/j.vesic.2023.100024_b18) 2019; 88 Wei (10.1016/j.vesic.2023.100024_b27) 2019; 6 Valencia-Hernandez (10.1016/j.vesic.2023.100024_b28) 2020; 6 Liu (10.1016/j.vesic.2023.100024_b17) 2018; 93 Chen (10.1016/j.vesic.2023.100024_b25) 2022; 3 Hao (10.1016/j.vesic.2023.100024_b34) 2022; 104 Döhring (10.1016/j.vesic.2023.100024_b31) 1997; 3-4 Connolly (10.1016/j.vesic.2023.100024_b29) 1990; 6 Yang (10.1016/j.vesic.2023.100024_b11) 2019; 205 Wu (10.1016/j.vesic.2023.100024_b36) 2020; 19 Webster (10.1016/j.vesic.2023.100024_b1) 2017; 25 Qi (10.1016/j.vesic.2023.100024_b15) 2018; 11 Liu (10.1016/j.vesic.2023.100024_b26) 2020; 6 Luzzago (10.1016/j.vesic.2023.100024_b6) 1993; 128 |
References_xml | – volume: 68–69 start-page: 248 year: 2018 ident: 10.1016/j.vesic.2023.100024_b16 article-title: Renal fibrosis: Primacy of the proximal tubule publication-title: Matrix Biol doi: 10.1016/j.matbio.2018.02.006 – volume: 25 start-page: 1238 year: 2017 ident: 10.1016/j.vesic.2023.100024_b1 article-title: Chronic kidney disease publication-title: Lancet doi: 10.1016/S0140-6736(16)32064-5 – volume: 6 start-page: 950 year: 2020 ident: 10.1016/j.vesic.2023.100024_b28 article-title: A natural peptide antigen within the plasmodium ribosomal protein RPL6 confers liver TRM cell-mediated immunity against malaria in mice publication-title: Cell Host Microbe doi: 10.1016/j.chom.2020.04.010 – volume: 4 start-page: 493 year: 2009 ident: 10.1016/j.vesic.2023.100024_b8 article-title: Mimotope vaccination–from allergy to cancer publication-title: Expert Opin Biol Ther doi: 10.1517/14712590902870386 – volume: 11 start-page: 1126 year: 2018 ident: 10.1016/j.vesic.2023.100024_b15 article-title: Renal tubular epithelial cells: the neglected mediator of tubulointerstitial fibrosis after injury publication-title: Cell Death Dis doi: 10.1038/s41419-018-1157-x – volume: 1 start-page: 17 year: 2015 ident: 10.1016/j.vesic.2023.100024_b19 article-title: Exosome and exosomal microRNA: trafficking, sorting, and function publication-title: Genom Proteom Bioinform doi: 10.1016/j.gpb.2015.02.001 – volume: 8 start-page: 496 year: 2016 ident: 10.1016/j.vesic.2023.100024_b2 article-title: The epidermal growth factor receptor pathway in chronic kidney diseases publication-title: Nat Rev Nephrol doi: 10.1038/nrneph.2016.91 – volume: 3 year: 2022 ident: 10.1016/j.vesic.2023.100024_b25 article-title: β-Catenin-controlled tubular cell-derived exosomes play a key role in fibroblast activation via the OPN-CD44 axis publication-title: J Extracell Vesicles – volume: 1 start-page: 79 year: 2017 ident: 10.1016/j.vesic.2023.100024_b32 article-title: Interferon-γ production by tubulointerstitial human CD56bright natural killer cells contributes to renal fibrosis and chronic kidney disease progression publication-title: Kidney Int doi: 10.1016/j.kint.2017.02.006 – volume: 9 start-page: 554 year: 2019 ident: 10.1016/j.vesic.2023.100024_b33 article-title: Tissue-resident natural killer cells exacerbate tubulointerstitial fibrosis by activating transglutaminase 2 and syndecan-4 in a model of aristolochic acid-induced nephropathy publication-title: BMB Rep doi: 10.5483/BMBRep.2019.52.9.193 – volume: 104 year: 2022 ident: 10.1016/j.vesic.2023.100024_b34 article-title: Shenkang injection protects against renal fibrosis by reducing perforin expression through the STING/TBK1/IRF3 signaling pathways in natural killer cells publication-title: Phytomedicine doi: 10.1016/j.phymed.2022.154206 – volume: 9 start-page: 795 year: 2019 ident: 10.1016/j.vesic.2023.100024_b4 article-title: Are mimotope vaccines a good alternative to monoclonal antibodies? publication-title: Immunotherapy doi: 10.2217/imt-2018-0213 – volume: 128 start-page: 51 year: 1993 ident: 10.1016/j.vesic.2023.100024_b6 article-title: Mimicking of discontinuous epitopes by phage-displayed peptides, I. Epitope mapping of human H ferritin using a phage library of constrained peptides publication-title: Gene doi: 10.1016/0378-1119(93)90152-S – volume: 128 start-page: 21 year: 1993 ident: 10.1016/j.vesic.2023.100024_b5 article-title: Mimicking of discontinuous epitopes by phage-displayed peptides, II. Selection of clones recognized by a protective monoclonal antibody against the Bordetella pertussis toxin from phage peptide libraries publication-title: Gene doi: 10.1016/0378-1119(93)90148-V – volume: 14 start-page: 4021 year: 2021 ident: 10.1016/j.vesic.2023.100024_b24 article-title: Tubular cell-derived exosomal miR-150-5p contributes to renal fibrosis following unilateral ischemia-reperfusion injury by activating fibroblast in vitro and in vivo publication-title: Int J Biol Sci doi: 10.7150/ijbs.62478 – volume: 113 start-page: 1 year: 2007 ident: 10.1016/j.vesic.2023.100024_b7 article-title: Mimotope vaccines: epitope mimics induce anticancer antibodies publication-title: Immunol Lett doi: 10.1016/j.imlet.2007.07.008 – volume: 12 year: 2015 ident: 10.1016/j.vesic.2023.100024_b14 article-title: Novel markers to delineate murine M1 and M2 macrophages publication-title: PLoS One – volume: 3 start-page: 255 year: 2021 ident: 10.1016/j.vesic.2023.100024_b23 article-title: HNRNPA1-mediated exosomal sorting of miR-483-5p out of renal tubular epithelial cells promotes the progression of diabetic nephropathy-induced renal interstitial fibrosis publication-title: Cell Death Dis doi: 10.1038/s41419-021-03460-x – volume: 6 start-page: 1181 year: 2020 ident: 10.1016/j.vesic.2023.100024_b26 article-title: Tubule-derived exosomes play a central role in fibroblast activation and kidney fibrosis publication-title: Kidney Int doi: 10.1016/j.kint.2019.11.026 – volume: 12 start-page: 3425 year: 2002 ident: 10.1016/j.vesic.2023.100024_b30 article-title: Mouse MHC class I tetramers that are unable to bind to CD8 reveal the need for CD8 engagement in order to activate naive CD8 T cells publication-title: Eur J Immunol doi: 10.1002/1521-4141(200212)32:12<3425::AID-IMMU3425>3.0.CO;2-7 – volume: 277 start-page: F26 year: 1999 ident: 10.1016/j.vesic.2023.100024_b13 article-title: Role of fas (CD95) in tubulointerstitial disease induced by unilateral ureteric obstruction publication-title: Am J Physiol – volume: 6 start-page: 2137 year: 1990 ident: 10.1016/j.vesic.2023.100024_b29 article-title: Recognition by CD8 on cytotoxic T lymphocytes is ablated by several substitutions in the class I alpha 3 domain: CD8 and the T-cell receptor recognize the same class I molecule publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.87.6.2137 – volume: 19 start-page: 120 year: 2020 ident: 10.1016/j.vesic.2023.100024_b36 article-title: Natural killer cells in cancer biology and therapy publication-title: Mol Cancer doi: 10.1186/s12943-020-01238-x – volume: 12 start-page: 1553 year: 2020 ident: 10.1016/j.vesic.2023.100024_b37 article-title: Tissue-resident NK cells: Development, maturation, and clinical relevance publication-title: Cancers (Basel) doi: 10.3390/cancers12061553 – volume: 47 year: 2020 ident: 10.1016/j.vesic.2023.100024_b9 article-title: Peptide mimotopes alter t cell function in cancer and autoimmunity publication-title: Sem Immunol doi: 10.1016/j.smim.2020.101395 – volume: 59 start-page: 1481 year: 2010 ident: 10.1016/j.vesic.2023.100024_b12 article-title: Identification and characterization of ch806 mimotopes publication-title: Cancer Immunol Immunother doi: 10.1007/s00262-010-0872-7 – volume: 6 start-page: 1162 year: 2019 ident: 10.1016/j.vesic.2023.100024_b27 article-title: Ribosomal proteins regulate MHC class I peptide generation for immunosurveillance publication-title: Mol Cell doi: 10.1016/j.molcel.2018.12.020 – volume: 1 year: 2022 ident: 10.1016/j.vesic.2023.100024_b3 article-title: Vaccination against her-2/neu, with focus on peptide-based vaccines publication-title: ESMO Open – volume: 3-4 start-page: 285 year: 1997 ident: 10.1016/j.vesic.2023.100024_b31 article-title: Major histocompatibility complex (MHC) class I recognition by natural killer cells publication-title: Crit Rev Immunol doi: 10.1615/CritRevImmunol.v17.i3-4.20 – volume: 205 start-page: 57 year: 2019 ident: 10.1016/j.vesic.2023.100024_b11 article-title: Epidermal growth factor receptor mimotope alleviates renal fibrosis in murine unilateral ureteral obstruction model publication-title: Clin Immunol doi: 10.1016/j.clim.2019.05.014 – volume: 163 start-page: 111 year: 2016 ident: 10.1016/j.vesic.2023.100024_b10 article-title: Mimotope mimicking epidermal growth factor receptor alleviates mononuclear cell infiltration in exocrine glands induced by muscarinic acetylcholine 3 receptor publication-title: Clin Immunol doi: 10.1016/j.clim.2016.01.006 – volume: 88 start-page: 487 year: 2019 ident: 10.1016/j.vesic.2023.100024_b18 article-title: Exosomes publication-title: Annu Rev Biochem doi: 10.1146/annurev-biochem-013118-111902 – volume: 18 start-page: 8660 year: 2021 ident: 10.1016/j.vesic.2023.100024_b21 article-title: Exosomal miR-21 from tubular cells contributes to renal fibrosis by activating fibroblasts via targeting PTEN in obstructed kidneys publication-title: Theranostics doi: 10.7150/thno.62820 – volume: 3 start-page: 385 year: 2013 ident: 10.1016/j.vesic.2023.100024_b20 article-title: TGF-β1-containing exosomes from injured epithelial cells activate fibroblasts to initiate tissue regenerative responses and fibrosis publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2012101031 – volume: 2 year: 2020 ident: 10.1016/j.vesic.2023.100024_b22 article-title: Injured tubular epithelial cells activate fibroblasts to promote kidney fibrosis through miR-150-containing exosomes publication-title: Exp Cell Res – volume: 93 start-page: 568 year: 2018 ident: 10.1016/j.vesic.2023.100024_b17 article-title: Renal tubule injury: a driving force toward chronic kidney disease publication-title: Kidney Int doi: 10.1016/j.kint.2017.09.033 – volume: 9 start-page: 1869 year: 2018 ident: 10.1016/j.vesic.2023.100024_b35 article-title: Natural killer cells: Development, maturation, and clinical utilization publication-title: Front Immunol doi: 10.3389/fimmu.2018.01869 |
SSID | ssj0003247512 |
Score | 2.2397544 |
Snippet | The high prevalence of chronic kidney disease (CKD) is a significant public health burden worldwide. Renal fibrosis is an inevitable pathological process in... |
SourceID | doaj crossref |
SourceType | Open Website Enrichment Source Index Database |
StartPage | 100024 |
SubjectTerms | Exosome Major histocompatibility complex-1B Mimotope Renal fibrosis Ribosomal protein L6 |
Title | MHC-1B carried exosomes derived from tubular epithelial cell induced by the EGFR mimotope inhibit macrophage activation in renal fibrosis |
URI | https://doaj.org/article/d29ca3f76dc94c4e84e1d73a0b7e6dc0 |
Volume | 2 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV07T8MwELYQEhIL4inKSx4YCeThPDzSqqVCKgOiUrfIj4ta1DZVm1Z0Yedfc5e0VVlgYclwdiLH38n3nX2-Y-w2QJthpZ8hc3OFI5ARORJZrpNBKBQyksSUG26dl6jdFc-9sLdV6otiwqr0wNXEPVhfGhVkcWSNFEZAIsCzcaBcHQPKSm8dbd6WM0VrMNKEGE3ZOs1QGdC1APzveyoXTqEBri9-mKKtjP2laWkdsoMVJ-SP1ViO2A6Mj9leVSVyecK-Ou2G49W5UVP0ay2Hj3yWj2DGLWrPAgV0RYQXc00RpRwmdMtiiGrFaVOeo8-N6FmulxzlvPnUeuUjAiifADb2B3pQ8JGiSl59XFs4XXSotmmxlU-BRpahT53PBrNT1m013xptZ1VBwTHo1ggnNibUtszJHiE_BSnQoKswQOR0qGPtK5mBklYZcCOZhJkIrbY2Ivw8OsM9Y7vjfAznjGeugshTEdVQESbOtEx8jb61FhCATLwa89eTmZpVenGqcjFM13Fk72mJQEoIpBUCNXa3eWlSZdf4vXudUNp0pdTYpQAVJl0pTPqXwlz8x0cu2T6Nq4pruWK7xXQO18hOCn1TKiI-O5_Nb-Uw5ls |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=MHC-1B+carried+exosomes+derived+from+tubular+epithelial+cell+induced+by+the+EGFR+mimotope+inhibit+macrophage+activation+in+renal+fibrosis&rft.jtitle=Extracellular+Vesicle+%28Online%29&rft.au=Jin+Guo&rft.au=Xuanqi+Liu&rft.au=Haoming+Song&rft.au=Yong+Gu&rft.date=2023-12-01&rft.pub=Elsevier&rft.eissn=2773-0417&rft.volume=2&rft.spage=100024&rft_id=info:doi/10.1016%2Fj.vesic.2023.100024&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_d29ca3f76dc94c4e84e1d73a0b7e6dc0 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2773-0417&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2773-0417&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2773-0417&client=summon |